Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

por Breder, Ikaro, Cunha Breder, Jessica, Bonilha, Isabella, Munhoz, Daniel B., Medorima, Sheila T. Kimura, Oliveira, Daniela C., do Carmo, Helison R., Moreira, Camila, Kontush, Anatol, Zimetti, Francesca, Zanotti, Ilaria, Carvalho, Luiz Sergio F., Nadruz, Wilson, Muscelli, Elza, Quinaglia, Thiago, Sposito, Andrei C.
Publicado 2020

RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19

por Davidson, Sean M., Lukhna, Kishal, Gorog, Diana A., Salama, Alan D., Castillo, Alejandro Rosell, Giesz, Sara, Golforoush, Pelin, Kalkhoran, Siavash Beikoghli, Lecour, Sandrine, Imamdin, Aqeela, do Carmo, Helison R. P., Bovi, Ticiane Gonçalez, Perroud, Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.
Publicado 2021

Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19

por Davidson, Sean M., Lukhna, Kishal, Gorog, Diana A., Salama, Alan D., Castillo, Alejandro Rosell, Giesz, Sara, Golforoush, Pelin, Kalkhoran, Siavash Beikoghli, Lecour, Sandrine, Imamdin, Aqeela, do Carmo, Helison R. P., Bovi, Ticiane Gonçalez, Perroud, Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.
Publicado 2021

Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial

por Lukhna, Kishal, do Carmo, Helison R. P., Castillo, Alejandro Rossell, Davidson, Sean M., Geffen, Hayli, Giesz, Sara, Golforoush, Pelin, Bovi, Ticiane Gonçalez, Gorag, Diana, Salama, Alan, Imamdin, Aqeela, Kalkhoran, Siavash, Lecour, Sandrine, Perroud Jr., Mauricio W., Ntsekhe, Mpiko, Sposito, Andrei C., Yellon, Derek M.
Publicado 2022

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

por Sposito, Andrei C., Breder, Ikaro, Soares, Alexandre A. S., Kimura-Medorima, Sheila T., Munhoz, Daniel B., Cintra, Riobaldo M. R., Bonilha, Isabella, Oliveira, Daniela C., Breder, Jessica Cunha, Cavalcante, Pamela, Moreira, Camila, Moura, Filipe A., de Lima-Junior, Jose Carlos, do Carmo, Helison R. P., Barreto, Joaquim, Nadruz, Wilson, Carvalho, Luiz Sergio F., Quinaglia, Thiago
Publicado 2021

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial

por Sposito, Andrei C., Breder, Ikaro, Barreto, Joaquim, Breder, Jessica, Bonilha, Isabella, Lima, Marcus, Oliveira, Alessandra, Wolf, Vaneza, Luchiari, Beatriz, do Carmo, Helison R., Munhoz, Daniel, Oliveira, Daniela, Coelho-Filho, Otavio R., Coelho, Otavio R., Matos-Souza, Jose Roberto, Moura, Filipe A., de Carvalho, Luiz Sergio F., Nadruz, Wilson, Quinaglia, Thiago, Kimura-Medorima, Sheila T.
Publicado 2022